An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
By O. Johnell, J. Kanis. Osteoporosis International, 2006
4,634 citations recorded by the source corpus.
Subfields: Orthopedics and Sports Medicine, Pediatrics, Perinatology and Child Health, Surgery
View Paper: https://www.semanticscholar.org/paper/30bb0389cfb21f380f4d0177832c5f01e2c99986
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Orthopedics and Sports Medicine
- J. Kanis
- Chris Cooper
- J. Reginster
- R. Rizzoli
- Eugene V. McCloskey
- H. Johansson
- on behalf of the International Osteoporosis Foundation
- F. Borgström
In Pediatrics, Perinatology and Child Health
In Surgery
- Eugene V. McCloskey
- Chris Cooper
- J. Reginster
- H. Johansson
- J. Kanis
- R. Rizzoli
- F. Borgström
- on behalf of the International Osteoporosis Foundation
Citations in the corpus
- Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men (2010, neutral): “random-effects categorical and meta-regression analyses (27) to examine whether findings were affected by the following subgroup characteristics: geographic region, defined according to the categories of the Global Burden of Disease 2000 World Health Organization member states project (28); register”
- Critical review: vegetables and fruit in the prevention of chronic diseases (2012, background): “rotic fracture is estimated to occur every 3 s, a vertebral fracture every 22 s [178].”
- Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image (2014, background): “With the aging world population, these staggering numbers are projected to double over the next 40 to 50 years with 6 million hip fractures expected to occur worldwide by 2050.((1))”
- Excess mortality following hip fracture: a systematic epidemiological review (2009, background): “and the mean age at first presentation is approximately 80 years [1, 2]. Johnell and Kanis estimated a worldwide incidence of 1.6 million osteoporotic fractures of the hip in people aged 50 years and older in 2000, of which about 70% (1.14 million) were in women [ 3 ].”
- The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro. (2010, background): “Annual direct costs due to osteoporosis-related fracture in the United States are estimated in the range of US$20 billion [1] and its disease burden in Europe is estimated to be greater than that attributed to any cancer save lung [2].”
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2018, background): “With regard to neoplastic diseases, the burden of osteoporosis was greater than for all sites of cancer, with the exception of lung cancers [17].”
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008, methodology): “(Reprinted from [3], with kind permission from Springer Science + Business Media) 269 307 451 490 1048 1217 1236 1359 2734 2936 3088 3453 2006”
- Osteoporosis: impact on health and economics (2010, background): “75% in Europe, where they are associated with more disability-adjusted life years than many other chronic noncommunicable diseases ( Figure 2 )”
- Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study (2011, background): “Given the need to balance the costs of treatment with the direct and indirect costs of osteoporotic fractures,((4,7,11)) it is important to optimize the prediction of fracture risk in order to identify those most likely to benefit from treatment.”